🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Impact of a Clinical Pathway for Pelvic Fragility Fractures

RecruitingNAAges 50 Years - anyAllAcademisch Medisch Centrum - Universiteit van Ams…
NCT06054165 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Patients with pelvic fragility fractures suffer from high morbidity and mortality rates. Despite the high incidence of these injuries, there is currently no regional or nationwide treatment protocol which results in a wide variety of clinical practice. New insights in treatment strategies, such as early diagnosis and minimal invasive operative treatment of these fragile patient population, has led to the development of several clinical pathways in recent literature. The aim of this study is to implement an evidence and experience-based treatment clinical pathway to improve the outcomes in this fragile patient population that currently has multifactorial risks for poor outcome.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Pelvic fragility fracture caused by low energetic trauma * Patients presented at the emergency room or out-patient clinic of a participating hospital Exclusion Criteria: * Patients with high suspicion of a pelvic fracture due to a malignant tumor * Patients who are unable to follow instructions due to severe cognitive decline (for example due to dementia or Alzheimer's disease) * Patients who pre-trauma received palliative or terminal care * Patients who pre-trauma were wheelchair bound or bedridden * Patients who suffer from complications from previous pelvic ring fixation * Patients with insufficient comprehension of the Dutch language to be able to carry out the physiotherapy instructions for early mobilization
💊

What it tests

  • Clinical pathway
📍

Where

8 sites
Flevoziekenhuis
Almere Stad, Netherlands
Noordwest Ziekenhuisgroep
Alkmaar, Netherlands
BovenIJ ziekenhuis
Amsterdam, Netherlands
OLVG
Amsterdam, Netherlands
Amsterdam UMC
Amsterdam, Netherlands
Spaarne Gasthuis
Haarlem, Netherlands
Dijklander Ziekenhuis
Hoorn, Netherlands
Zaans Medisch Centrum
Zaandam, Netherlands
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy